Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
Vitamin D insufficiency and chronic diseases: Hype and reality.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Benchmarks of meaningful impairment on the MSFC and BICAMS.
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
IL-12, but not IL-23, induces the expression of IL-7 in microglia and macrophages: Implications for multiple sclerosis.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
[Affective and psychotic disorders in multiple sclerosis].
Advances in the management of MS symptoms: real-life evidence.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Cell-Based Modulation of Autoimmune Responses in Multiple Sclerosis and Experimental Autoimmmune Encephalomyelitis: Therapeutic Implications.
Visualizing iron in multiple sclerosis.
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »